Related Articles & Quotes
Orthopedics Today, through the sponsorship of Nutramax laboratories, Inc and Bioiberica SA, assembled a panel of experts to discuss the role of chondroitin sulfate in the management of osteoarthritis.
A monograph of this symposium was published by Othopedics Today in June 2003 and copies are available from Biocel Australia on request.
Some of what these experts say:
"I put my patients on LMW chondroitin sulfate with glucosamine for symptomatic benefit."
"I recommend that all patients use LMW chondroitin sulfate and glucosamine for a three-month trial."
"Having a purified product is critical. Physicians should not categorise all chondroitin sulfate products as if they are the same."
Professor David Hungerford, Department of Orthopedic Surgery, Johns Hopkins University, Baltimore, Maryland.
"I routinely encourage the use of LMW chondroitin sulfate with glucosamine as a first-line measure in the management of osteoarthritis."
"Chondroitin sulfate and glucosamine are safe and effective"
"I see athletes who continue to play a sport although they have osteochondral contusions or bone bruises of the knee, tibia, talus or foot. I put these patients on LMW chondroitin sulfate with glucosamine to give them the best chance of some articular repair."
Ass. Prof. Nicholas DiNublie, Department of Orthopedic Surgery, University of Pennsylvania.
"I recommend using the LMW chondroitin sulfate with glucosamine supplement that has been used in clinical trials."
"Approximately 40% of my patients already take chondroitin sulfate with glucosamine. This supplement has been effective in clinical trials for mild to moderate arthritis with minimal adverse effects."
Professor Robert Shenck, Orthopedic Surgery and Head of Division of Sports Medicine, University of New Mexico, Albuquerque.
"There is considerable variability in the bioavailability and the clinical effect of the various chondroitin sulfate products. Physicians must recommend products that have been clinically tested and that are consistent in quality like Cosamin DS...."
Dr Kelly Krohn, Director of Clinical research, Department of Medicine and Clinical Rheumatologist, Division of Rheumatology, Mercy Hospital, Pittsburg, Pennsylvania.